Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization Sort descending	Title	Grant Number	Program Official
Permuth, Jennifer B	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-07	Matthew Young, Ph.D.
Fiol, Guilherme Del	Utah State Higher Education System--University Of Utah United States	GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management	5U24CA274582-03	Christos Patriotis, Ph.D., M.Sc.
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	5U01CA113913-18	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer	5R01CA254036-05	Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer	3U01CA214254-08S2	Matthew Young, Ph.D.
Ricciardiello, Luigi	University Of Tx Md Anderson Can Ctr United States	Great Lakes New England Clinical Validation Center	4U01CA086400-24	Matthew Young, Ph.D.
Stachler, Matthew D	University Of California, San Francisco United States	Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus	5R37CA269649-04	Matthew Young, Ph.D.
Lampe, Paul D.	Fred Hutchinson Cancer Center United States	Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer	5R01CA281801-03	Guillermo Marquez, Ph.D.
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	5R21CA282380-02	Wendy Wang, Ph.D., M.Sc.
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Early detection of colorectal cancer in the traditional and serrated pathways	5R01CA249851-05	Guillermo Marquez, Ph.D.
Majumder, Shounak	Mayo Clinic Rochester United States	Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer	5U01CA210138-09	Matthew Young, Ph.D.
Godwin, Andrew K.	University Of Kansas Medical Center United States	Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem	5R01CA260132-05	Matthew Young, Ph.D.
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-04	Guillermo Marquez, Ph.D.
Zhang, Zhen	Johns Hopkins University United States	A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach	5U2CCA271891-04	Christos Patriotis, Ph.D., M.Sc.
Lin, Jia-Ren	Harvard Medical School United States	Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images	5R50CA274277-04	Guillermo Marquez, Ph.D.